JAMES WATSON and Francis Crick had no idea that they would kick-start the next industrial revolution when they discovered the legendary double helix 50 years ago. Now companies all over the globe are building on their discovery in the hunt for new drugs. And not surprisingly, the land where the structure of DNA was stripped bare has been a particular success at nurturing the biotech industry.
But it hasn’t all been plain sailing. Though several unique, British-developed biotech drugs to combat conditions such as migraine and rheumatoid arthritis were approved last year, it’s only recently that a steady stream of British biotechnology companies became profitable. And…
